These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 18937388)

  • 1. Review: nonergot dopamine agonists reduce symptoms in the restless legs syndrome but may be discontinued due to adverse events.
    Kaushik S; Blanchard AR
    ACP J Club; 2008; 149(4):10. PubMed ID: 18937388
    [No Abstract]   [Full Text] [Related]  

  • 2. ACP Journal Club. Review: Dopamine agonists are effective for the restless legs syndrome but may be discontinued due to adverse events.
    Andolsek KM
    Ann Intern Med; 2011 Jul; 155(2):JC1-9. PubMed ID: 21768575
    [No Abstract]   [Full Text] [Related]  

  • 3. An exploratory retrospective evaluation of ropinirole-associated psychotic symptoms in an outpatient population treated for restless legs syndrome or Parkinson's disease.
    Stoner SC; Dahmen MM; Makos M; Lea JW; Carver LJ; Rasu RS
    Ann Pharmacother; 2009 Sep; 43(9):1426-32. PubMed ID: 19690226
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Restless legs syndrome: diagnostic time-savers, Tx tips.
    Moyer DE; Zayas-Bazan J; Reese G
    J Fam Pract; 2009 Aug; 58(8):415-23. PubMed ID: 19679021
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dopamine dysregulation syndrome in a patient with restless legs syndrome.
    Leu-Semenescu S; Karroum E; Brion A; Konofal E; Arnulf I
    Sleep Med; 2009 Apr; 10(4):494-6. PubMed ID: 19410183
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Restless legs syndrome.
    Ekbom K; Ulfberg J
    J Intern Med; 2009 Nov; 266(5):419-31. PubMed ID: 19817966
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Critical review of ropinirole and pramipexole - putative dopamine D(3)-receptor selective agonists - for the treatment of RLS.
    Varga LI; Ako-Agugua N; Colasante J; Hertweck L; Houser T; Smith J; Watty AA; Nagar S; Raffa RB
    J Clin Pharm Ther; 2009 Oct; 34(5):493-505. PubMed ID: 19744006
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bupropion as a possible treatment option for restless legs syndrome.
    Lee JJ; Erdos J; Wilkosz MF; LaPlante R; Wagoner B
    Ann Pharmacother; 2009 Feb; 43(2):370-4. PubMed ID: 19193596
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Restless legs, restless nights: therapeutic options in RLS].
    Kassubek J; Unrath A
    MMW Fortschr Med; 2009 Mar; 151(13):65-7, 69. PubMed ID: 19504823
    [No Abstract]   [Full Text] [Related]  

  • 10. Restless legs syndrome.
    Ondo WG
    Neurol Clin; 2009 Aug; 27(3):779-99, vii. PubMed ID: 19555831
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gabapentin enacarbil, a gabapentin prodrug for the treatment of the neurological symptoms associated with disorders such as restless legs syndrome.
    Merlino G; Serafini A; Young JJ; Robiony F; Gigli GL; Valente M
    Curr Opin Investig Drugs; 2009 Jan; 10(1):91-102. PubMed ID: 19127491
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Secondary restless legs syndrome].
    Oka Y; Ioue Y
    Brain Nerve; 2009 May; 61(5):539-47. PubMed ID: 19514514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Restless leg syndrome, dopamine agonists and sleep attacks.
    Rose AR; Antic NA; McEvoy RD
    Intern Med J; 2008 Nov; 38(11):872-3. PubMed ID: 19120542
    [No Abstract]   [Full Text] [Related]  

  • 14. In restless legs syndrome, the neural substrates of the sensorimotor symptoms are also normally involved in upright standing posture and biped walking.
    Akpinar S
    Med Hypotheses; 2009 Aug; 73(2):169-76. PubMed ID: 19394150
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of non-ergot dopamine agonists on health-related quality of life of patients with restless legs syndrome.
    Talati R; Phung OJ; Mather J; Coleman CI
    Ann Pharmacother; 2009 May; 43(5):813-21. PubMed ID: 19401472
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Restless legs syndrome caused by quetiapine successfully treated with ropinirole in 2 patients with bipolar disorder.
    Urbano MR; Ware JC
    J Clin Psychopharmacol; 2008 Dec; 28(6):704-5. PubMed ID: 19011442
    [No Abstract]   [Full Text] [Related]  

  • 17. [Restless legs syndrome].
    Stegelmeyer U; Töpper R
    Fortschr Neurol Psychiatr; 2008 Dec; 76(12):734-42; quiz 743-5. PubMed ID: 19053012
    [No Abstract]   [Full Text] [Related]  

  • 18. Dopamine agonists restore cortical plasticity in patients with idiopathic restless legs syndrome.
    Rizzo V; Aricò I; Mastroeni C; Morgante F; Liotta G; Girlanda P; Silvestri R; Quartarone A
    Mov Disord; 2009 Apr; 24(5):710-5. PubMed ID: 19117337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Rest-activity rhythm, sleep pattern and quality of life in patients with restless legs syndrome].
    Lee EJ
    J Korean Acad Nurs; 2009 Jun; 39(3):422-32. PubMed ID: 19571639
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of pramipexole on RLS symptoms and sleep: a randomized, double-blind, placebo-controlled trial.
    Ferini-Strambi L; Aarskog D; Partinen M; Chaudhuri KR; Sohr M; Verri D; Albrecht S
    Sleep Med; 2008 Dec; 9(8):874-81. PubMed ID: 18952497
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.